Helbig, Grzegorz, Grazyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf, Lech Sedlak, Tomasz Oleksy, and Slawomira Kyrcz-Krzemien. “OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE”. Mediterranean Journal of Hematology and Infectious Diseases 7, no. 1 (January 1, 2015): e2015003. Accessed September 20, 2020. https://mjhid.org/index.php/mjhid/article/view/2015.003.